home / stock / mck / mck articles

MCK Articles, McKesson Corporation - From 03/18/24

Stock Information
Company Name: McKesson Corporation
Stock Symbol: MCK
Market: NYSE
Website: mckesson.com
Menu
MCK MCK Quote MCK Short MCK News MCK Articles MCK Message Board
Get MCK Alerts

News, Short Squeeze, Breakout and More Instantly...
Which Stocks Will Dominate The Future Of Tech? UBS Shares Its Top Picks In AI, Healthtech, Greentech, And Fintech | Benzinga

In a recent report, global wealth manager UBS identified the sectors likely to drive the next wave of technological innovation and the stocks that ...
US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation | Benzinga

The Federal Trade Commission (FTC) is reportedly launching an investigation into recent shortages of chemotherapies, including carboplatin, cisplat...

Medical Supplies-Focused McKesson Shares Fall On Q3 Earnings Performance, Analyst Says Street 'Wanted More' | Benzinga

Wednesday, McKesson Corporation (NYSE:MCK) reported that third-quarter 2024 sales of $80.9 billion increased 15%, beating the consen...

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,900 Today | Benzinga

McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 17.87% on an annualized basis producing an average annual return of 30.54%...
McKesson Earnings Are Imminent; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts | Benzinga

McKesson Corporation (NYSE: MCK) is expected to release earnings results for its third quarter, after the closing bell on Feb. 7, 2024. Analysts e...

Fear & Greed Index Remains In 'Greed' Zone Following Earnings Reports; Dow Jumps Over 100 Points | Benzinga

The CNN Money Fear and Greed index showed a slight improvement in the overall market sentiment, while the index remained in the "Greed" z...

Here's How Much $1000 Invested In McKesson 5 Years Ago Would Be Worth Today | Benzinga

McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 18.66% on an annualized basis producing an average annual return of 31.4%....
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $12,000 Today | Benzinga

McKesson (NYSE:MCK) has outperformed the market over the past 15 years by 6.14% on an annualized basis producing an average annual return of 18.03%...

Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug | Benzinga

The FDA approved Calliditas Therapeutics AB's (NASDAQ: CALT) Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidn...

Here's How Much $100 Invested In McKesson 15 Years Ago Would Be Worth Today | Benzinga

McKesson (NYSE:MCK) has outperformed the market over the past 15 years by 7.77% on an annualized basis producing an average annual return of 19.11%...
Previous 10 Next 10